MedTrace Logo

Registry of Subject Treated With ClariFix

NCT03739216 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 354

Last updated 2021-08-03

No results posted yet for this study

Summary

A multi-center, prospective, non-randomized, observational registry to asses the results of the ClariFix(TM) device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis.

Conditions

  • Chronic Rhinitis

Interventions

DEVICE

ClariFix

The ClariFix device is a handheld cryosurgical device which provides focal, controlled freezing to the target tissue.

Sponsors & Collaborators

  • Arrinex, Inc.

    lead INDUSTRY

Principal Investigators

  • Amber U Luong, MD, PhD · UT Health - The University of Texas

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-13
Primary Completion
2021-06-15
Completion
2021-06-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03739216 on ClinicalTrials.gov